EX-1 2 ex_1.htm EXHIBIT 1
 

EXHIBIT 1

 

JOINT FILING AGREEMENT

 

In accordance with Rule 13d-1(f) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of this Schedule 13G (including amendments thereto) with respect to the Common Stock of BioScrip, Inc. and further agree that this Joint Filing Agreement be included as an Exhibit to such joint filing.  In evidence thereof, the undersigned, hereby execute this Agreement this January 26, 2018.

 

  January 26, 2018  
  Date  
     
  ARDSLEY ADVISORY PARTNERS  
     
  /s/ Steve Napoli  
  Signature  
     
  Steve Napoli/Partner  
  Name/Title  
     
  January 26, 2018  
  Date  
     
  ARDSLEY PARTNERS I  
     
  /s/ Steve Napoli  
  Signature  
     
  Steve Napoli/General Partner  
     
  January 26, 2018  
  Date  
     
  PHILIP J. HEMPLEMAN  
     
  /s/ Steve Napoli*  
  Signature  
     
  Steve Napoli/Attorney-in Fact for Philip J. Hempleman  
  Name/Title  

 
 

  January 26, 2018  
  Date  
     
  ARDSLEY PARTNERS FUND II, L.P.  
  By: Ardsley Partners I, General Partner  
     
  /s/ Steve Napoli  
  Signature  
 
  Steve Napoli/General Partner  
     
  January 26, 2018  
  Date  
     
  ARDSLEY PARTNERS ADVANCED HEALTHCARE FUND, L.P.  
 

By: Ardsley Partners I, General Partner

  
     
  /s/ Steve Napoli  
  Signature  
     
  Steve Napoli/General Partner  
     
  January 26, 2018  
  Date  
     
  ARDSLEY DUCKDIVE FUND, L.P.  
 

By: Ardsley Partners I, General Partner

  
     
  /s/ Steve Napoli  
  Signature  
     
  Steve Napoli/General Partner  
     
  January 26, 2018  
  Date  
     
  ARDSLEY HEALTHCARE FUND, L.P.  
 

By: Philip Hempleman, General Partner

  
     
 

Steve Napoli/Attorney-in Fact for Philip J. Hempleman

  
 

Name/Title

  
     
 

Steve Napoli/General Partner

  

 

* Executed by Steve Napoli as Attorney-in-Fact for Philip J. Hempleman. The Power of Attorney for Mr. Hempleman is attached as Exhibit 2 to the Statement on Schedule 13G/A with respect to the Common Stock of Vaxgen, Inc., filed on February 15, 2006, and is incorporated herein by reference.